Safety of electrical cardioversion in patients with previous embolic events

Mayo Clinic Proceedings

Volumn 76, Issue 4, 2001, Pages 364-368

  Elhendy, Abdou ^a   Gentile, Federico ^a   Khandheria, Bijoy K ^a   Bailey, Kent R ^a   Burger, Kelli N ^a   Seward, James B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; SAFETY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0035082767     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.4.364     Document Type: Article

References (23)

1. Nonrheumatic atrial fibrillation: Risk of stroke and role of antithrombotic therapy
2. Risk of thromboembolic events in patients with atrial flutter
3. Thromboembolism in chronic atrial flutter: Is the risk underestimated?
4. Risk of thromboembolism in chronic atrial flutter
5. Left atrial spontaneous contrast echoes - Markers of thromboembolic risk in patients with atrial fibrillation
6. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy
7. Cardioversion in atrial fibrillation: Indications, thromboembolic prophylaxis, and role of transesophageal echocardiography
8. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation
9. Functional capacity before and after cardioversion of atrial fibrillation: A controlled study
10. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
11. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
12. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated
13. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter: A prospective study using transesophageal echocardiography
14. Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter
15. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events
16. Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation
17. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
18. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
19. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis
20. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: A multicenter study
21. American College of Chest Physicians: Third ACCP Consensus Conference on Antithrombotic Therapy
22. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
23. Aortic plaque in atrial fibrillation: Prevalence, predictors, and thromboembolic implications